Skip to content

Provider review

Pallas Health semaglutide cost & review

Publishes its price openly, and there is no month to buy.

Every figure it advertises is a monthly average of a twelve-week block paid up front; the block is the only cadence it sells.

Price, exactly as they publish it

$199/mo average — Pallas's own figure for $597 billed every 12 weeks, its only cadence; $139 covers the first 4 weeks

Checked against Pallas Health's own site on . Prices move — confirm yours before you pay.

Check Pallas Health pricing

Semaglutide is prescription-only and compounded semaglutide is not the FDA-approved brand product — decide with a clinician. Prices are as the provider published them when we last checked; confirm current terms before you buy.

How Semawise makes money (plainly)

Here's the honest version: some of the links on this site are affiliate links, routed through the Katalys network. Click one and go on to start a treatment or buy something, and we may earn a commission — without costing you a single penny more. That's what keeps the lights on and the answers free. The part that matters: a commission never buys a softer review, a different price, or kinder pros and cons. What it does buy is position — affiliate partners are listed ahead of providers we have no relationship with, and we say so on each ranking rather than only here. Want the longer version? It's all in our full disclosure.

The verdict

Pallas Health does the thing this site asks for and then does something that undoes half of it. The good half is real: both molecules are priced in public, before any intake, with the amount actually charged stated rather than hidden behind a quiz, and with a genuinely reduced first cycle on each. The half that undoes it is the cadence. Those blocks cover twelve weeks and there is no monthly option underneath them, so the per-month figure you will see quoted is arithmetic Pallas performed on its own block, not a payment anyone makes. Worse for anyone budgeting: twelve weeks is not a quarter. A year is 4.33 of those cycles rather than four, so the annual cost sits above four times the block, and the monthly average understates what you will actually have paid twelve months from now. It also runs a Spanish-language lander alongside the English one.

The trade-off we'd want you to read first

There is no monthly rung at all. The only cadence is $597 paid up front every twelve weeks, so the advertised 'per month' figure is arithmetic rather than a payment anyone makes

Who it suits, and who it doesn't

A good fit if

  • You are comfortable paying a quarter at a time and want the full charged amount stated before you start
  • You want the first cycle discounted in a way you can see, rather than an intro rate that appears at checkout
  • You read Spanish and would rather deal with a provider that publishes in it

Look elsewhere if

  • You want a month-to-month plan you can stop after one cycle — there is no monthly rung here at all
  • You budget by calendar month: a twelve-week cycle is 4.33 charges a year, so the advertised average is lower than your real monthly cost
  • You are comparing on advertised figures across this ranking — this one is an average of a prepaid block, not a rate

How the program actually works

A cash-pay telehealth selling compounded semaglutide and tirzepatide in twelve-week blocks, priced publicly before any intake. There is no month-to-month option: the block is the only cadence, paid up front, with a reduced first four weeks on each molecule. It also runs a Spanish-language lander alongside the English site.

At a glance

Pricing structure
Varies by dose, plan or tier
Consult
Included in the price
Compounding pharmacy
Not publicly identified
Labs
Not required
Dietitian support
Not included

Source and full evidence quote in our Provenance Register.

What it does well

  • Semaglutide is priced publicly, with the amount actually charged stated rather than only a monthly average
  • A genuinely reduced first cycle at $139 for the first four weeks
  • Runs a Spanish-language lander as well as the English site, which most of this field does not

The other trade-offs

  • A 12-week cycle is 4.33 charges a year, not 4 — a year costs more than four times the block
  • The $139 first cycle is an intro rate; the standing block applies from the second cycle on
  • Its own disclaimer says Pallas “does not manufacture or compound medication” and that “compounded medications are prepared by US-licensed compounding pharmacies” — plural and unnamed, so there is no pharmacy to look up before you pay
  • Compounded semaglutide is not an FDA-approved product and is not a generic of Wegovy or Ozempic

If this one isn't it

If Pallas Health is not it, these are not our favorites and they are not the ones that pay the most — each is the provider closest to this one that does better on the axis this one does worst on. The axis is named on every card, with both providers’ own published wording underneath, so you can check the claim rather than take it.

Any link on this page may earn us a commission if you go on to start care, at no extra cost to you — see our full disclosure. The cards above are chosen by the rule stated at the top of this section, which is computed from published figures and has no access to which providers pay us.

Before you buy

Semaglutide is a prescription medicine, and the compounded version is not the same regulated product as brand-name Wegovy or Ozempic. Whatever you decide, decide it with a clinician who knows your history — and go into that conversation with real numbers.

Where this sits in the ranking

Pallas Health is one of 60 telehealth semaglutide programs we track. The ranking puts every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to, rather than only in the small print.

Semaglutide is prescription-only and compounded semaglutide is not the FDA-approved brand product — decide with a clinician. Prices are as the provider published them when we last checked; confirm current terms before you buy.